World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
13438
World Ranking
3235
National Ranking
279

Paul Bowness publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paul Bowness sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 275 publications — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Paul Bowness D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul Bowness sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Paul Bowness is affiliated with the University of Oxford in the United Kingdom. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a significant concentration in the subfields of Rheumatology, Immunology, Hematology, Molecular Biology, and Infectious Diseases. This focus is reflected in the extensive body of work investigating autoimmune and inflammatory disorders as well as infectious diseases.

The scientist's scholarly contributions cover a range of topics including:

  • Spondyloarthritis Studies and Treatments
  • Psoriasis: Treatment and Pathogenesis
  • Autoimmune and Inflammatory Disorders Research
  • Rheumatoid Arthritis Research and Therapies
  • T-cell and B-cell Immunology
  • Systemic Lupus Erythematosus Research
  • COVID-19 Clinical Research Studies

Paul Bowness has published numerous articles in various academic venues. The most frequent publication platforms include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Annals of the Rheumatic Diseases
  • Zenodo (CERN European Organization for Nuclear Research)
  • Frontiers in Immunology
  • Lara D. Veeken

Among the recent notable papers authored or co-authored by Paul Bowness are:

  • "A blood atlas of COVID-19 defines hallmarks of disease severity and specificity," 2022, published in Cell
  • "An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease," 2021, published in Nature Immunology
  • "Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis," 2020, published in Nature Communications
  • "Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides," 2022, published in Nature
  • "New developments in our understanding of ankylosing spondylitis pathogenesis," 2020, published in Immunology

The scientist frequently collaborates with other researchers. Their most common co-authors include:

  • Julian C. Knight
  • Frank Penkava
  • Hai Fang
  • Hussein Al-Mossawi
  • Andrew Brown

Best Publications

  • Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    D M Evans;Spencer Cca.;J J Pointon;Z Su

  • Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

    A Cortes;J Hadler;J P Pointon

  • CD56bright Human NK Cells Differentiate Into CD56dim Cells: Role of Contact With Peripheral Fibroblasts

    Antoni Chan;Deng-Li Hong;Ann Atzberger;Simon Kollnberger

  • A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

    Unknown

  • Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties.

    Eva Billerbeck;Yu Hoi Kang;Lucy Walker;Helen Lockstone

  • Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure.

    Rachel L. Allen;Chris A. O’Callaghan;Andrew J. McMichael;Paul Bowness

  • Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    D.M. Evans;C.C.A. Spencer;J.J. Pointon;Z. Su

  • Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis.

    Paul Bowness;Anna Ridley;Jacqueline Shaw;Antoni T. Chan;Antoni T. Chan

  • Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1.

    Adrian Cortes;Sara L. Pulit;Paul J. Leo;Jenny J. Pointon

  • Cell‐surface expression and immune receptor recognition of HLA–B27 homodimers

    Simon Kollnberger;Lucy Bird;Mei-Yi Sun;Christelle Retiere

  • Hereditary C1q deficiency and systemic lupus erythematosus.

    P. Bowness;K.A. Davies;P.J. Norsworthy;P. Athanassiou

  • Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming.

    G Kochan;T Krojer;D Harvey;R Fischer

  • CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses

    Ariane Hammitzsch;Cynthia Tallant;Oleg Fedorov;Alison O’Mahony

  • Lymphoblastoid cells express HLA-B27 homodimers both intracellularly and at the cell surface following endosomal recycling.

    Lucy A Bird;Chen Au Peh;Simon Kollnberger;Tim Elliott

  • Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis

    A T Chan;S D Kollnberger;L R Wedderburn;P Bowness

  • A genetics-led approach defines the drug target landscape of 30 immune-related traits

    H Fang;H De Wolf;B Knezevic;K L Burnham

  • A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis.

    T Schwerd;Twigg Srf.;D Aschenbrenner;S Manrique

  • Autoimmunity-associated T cell receptors recognize HLA-B*27-bound peptides

    Unknown

  • An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease

    Yanchun Peng;Suet Ling Felce;Danning Dong;Danning Dong;Frank Penkava

  • Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response.

    Eva Dazert;Christoph Neumann-Haefelin;Stéphane Bressanelli;Karen Fitzmaurice

  • Identification of HLA-B27-Restricted Peptides from the Chlamydia trachomatis Proteome with Possible Relevance to HLA-B27-Associated Diseases

    Wolfgang Kuon;Hermann-Georg Holzhütter;Heiner Appel;Martina Grolms

  • Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis.

    Frank Penkava;Martin Del Castillo Velasco-Herrera;Matthew D. Young;Nicole Yager

  • HLA-B27 Heavy Chain Homodimers Are Expressed in HLA-B27 Transgenic Rodent Models of Spondyloarthritis and Are Ligands for Paired Ig-Like Receptors

    Simon Kollnberger;Lucy A. Bird;Matthew Roddis;Cecile Hacquard-Bouder

  • Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

    A. Cortes;J. Hadler;J.P. Pointon;P.C. Robinson

Frequent Co-Authors

Andrew J. McMichael
Andrew J. McMichael University of Oxford
Paul Klenerman
Paul Klenerman University of Oxford
Benedikt M. Kessler
Benedikt M. Kessler University of Oxford
Julian C. Knight
Julian C. Knight University of Oxford
Jaakko Tuomilehto
Jaakko Tuomilehto University of Helsinki
David Evans
David Evans University of Bristol
Matthew A. Brown
Matthew A. Brown Guy's and St Thomas' NHS Foundation Trust
Roman Fischer
Roman Fischer University of Oxford
Robert D. Inman
Robert D. Inman University of Toronto
Maxime Breban
Maxime Breban University of Paris-Saclay

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare roles, many of which can be pursued through specialized online degrees. For those interested in advancing clinical practice, an accelerated NP program offers a fast-track pathway to becoming a nurse practitioner, blending in-depth immunology knowledge with patient care skills.

Individuals without a nursing background can explore quality options through the best online RN programs for non nurses. These programs are designed to transition non-nurses into registered nurses efficiently, often featuring flexible online formats.

For those aiming to enter nursing swiftly, the easiest ABSN to get into can be a strategic choice. These accelerated bachelor’s programs provide a practical route to integrate immunology principles into a nursing career.

In addition, beginning a healthcare career is possible through accessible LPN programs easy to get into. These programs help students build foundational medical knowledge, including aspects of immunology, while preparing for licensed practical nursing roles.

Best Scientists Citing Paul Bowness

Trending Scientists

Recently Published Articles